DONGKOO BIO & PHARMA CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 006620 for the last quarter is 66.18 B KRW, and it's 7.95% higher compared to the previous quarter. The net income of Q3 24 is 3.58 B KRW.